Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer-Reference-Cited by-同舟云学术

Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer

Published:2019-02 Issue: Volume:122 Page:338-347
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Vaidya Bhuvaneshwar,Parvathaneni Vineela^ORCID,Kulkarni Nishant S.,Shukla Snehal K.,Damon Jenna K.,Sarode Apoorva,Kanabar Dipti,Garcia Jerome V.,Mitragotri Samir,Muth Aaron,Gupta Vivek

Funder

St. John's University

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference42 articles.

1. Lung cancer statistics;Torre;Adv. Exp. Med. Biol.,2016

2. Treatment of non-small-cell lung cancer with erlotinib or gefitinib;Cataldo;N. Engl. J. Med.,2011

3. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer;Mandal;Eur. J. Pharm. Sci.,2016

4. Drug resistance to EGFR tyrosine kinase inhibitors for non-small cell lung cancer;Shien;Acta Med. Okayama,2014

5. Smart chemistry-based nanosized drug delivery systems for systemic applications: a comprehensive review;Ramasamy;J. Control. Release,2017

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Importance of nano-carriers, surfactant system, and their loading mechanism to improve the absorption and bio-availability of drugs: a review;Advances in Natural Sciences: Nanoscience and Nanotechnology;2024-08-22

2. Development and Applications of PLGA Hydrogels for Sustained Delivery of Therapeutic Agents;Gels;2024-07-26

3. Harnessing nanotechnology for enhanced delivery of erlotinib: a dynamic duo in cancer treatment;Beni-Suef University Journal of Basic and Applied Sciences;2024-07-26

4. Nanoparticle-based targeted therapy through EGFR tyrosine kinase inhibitors and their recent advances in lung cancer therapy;Exploration of Medicine;2024-07-14

5. Supramolecularly-Cross-Linked Nanogel Assemblies for On-Demand, Ultrasound-Triggered Chemotherapy;Biomacromolecules;2024-07-12